This funding supports a network of clinical trials focused on canine cancer immunotherapy to evaluate safe and effective cancer treatments relevant to humans. It includes awards for a coordinating center and multiple clinical trial sites conducting immunotherapy studies alone or combined with other treatments. The program aims to advance canine immunotherapeutics and analytics, providing valuable translational data while ethically benefiting pet dogs.
Eligible applicants include state, county, city, and tribal governments; public and private higher education institutions; nonprofits; for-profit organizations; small businesses; and various other entities including federal agencies and foreign institutions.
